Many of the latest developments in the global coronavirus pandemic revolve around testing — for active infection and immunity. Diagnostic and antibody tests for COVID-19 and SARS-CoV-2 are flooding the market, as leaders and the public hope they might support safer strategies for re-opening.

Ping Wang, PhD, DABCC, FAACC, an associate professor of Pathology and Laboratory Medicine, investigates diagnostics and diagnostic technology at Penn. Her clinical work focuses on making sure diagnostic results are delivered accurately and in a timely manner for patients at the Hospital at the University of Pennsylvania. Her research interests align with that, focusing on developing novel diagnostic tools — something particularly useful when facing a novel virus like SARS-CoV-2.

READ MORE